{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:12:59Z","timestamp":1778685179841,"version":"3.51.4"},"reference-count":34,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Hungarian National Research, Development and Innovation Office","award":["K 138816"],"award-info":[{"award-number":["K 138816"]}]},{"name":"Ministry for Culture and Innovation","award":["2025-2.1.1-EK\u00d6P-2025-00014"],"award-info":[{"award-number":["2025-2.1.1-EK\u00d6P-2025-00014"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,17]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Appropriate antibiotic (AB) therapy remains a challenge in intensive care units (ICUs). Guidelines recommend against using procalcitonin (PCT) to guide the initiation of AB therapy, although with low certainty and a very low level of evidence. Recent studies suggest that changes in PCT levels may be more accurate than a single measurement; however, this has never been tested in a randomised trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>In this multicentre, randomised controlled trial (RCT), we aim to compare the efficacy and safety of two different PCT protocols for initiating AB therapy. Hemodynamically stable, critically ill adult patients with suspected new-onset infection at admission or during ICU stay will be randomised in a 1:1 ratio. In the treatment arm (Kinetics Group, KG), initiation of AB treatment is strongly recommended if PCT \u22650.5\u2009ng\/mL and increases by more than 100% compared with the previous day. In the control arm (Absolute Group, AG), the initiation of AB treatment is strongly recommended if PCT \u22650.5\u2009ng\/mL. The primary outcome will be the rate of unnecessary AB therapy: 72 hours after recruitment, an independent intensivist, microbiologist and infectologist will determine whether the therapy was necessary, using all relevant clinical, microbiological and radiographic results. If no consensus is reached, a decision will be made by secret vote. We plan to enrol 250 participants in the study, with 80% statistical power and a 5% alpha level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval was obtained from the National Centre for Public Health and Pharmacy (BM\/20019\/2025). We plan to present our results at relevant national and international conferences and meetings and to submit them for publication in a peer-reviewed journal. Moreover, we plan to disseminate the results to important stakeholders in the Hungarian healthcare system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      This is the first version of the trial protocol, prepared in accordance with the SPIRIT 2025 guideline (version 1.0, dated 30 September 2025). The trial has been registered on ClinicalTrials.gov (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT07211620\">NCT07211620<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-115344","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:26:01Z","timestamp":1778682361000},"page":"e115344","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic use (KIPRUN): protocol for a multicentre, randomised, superiority trial to compare the efficacy and safety of procalcitonin kinetics-guided and absolute procalcitonin value-guided antibiotic initiation in critically ill patients"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct07211620","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct07211620","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0765-794X","authenticated-orcid":false,"given":"M\u00e1rton","family":"Papp","sequence":"first","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University, Budapest, Hungary"},{"name":"Department of Intensive Therapy, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caner","family":"Turan","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University, Budapest, Hungary"},{"name":"Department of Intensive Therapy, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolett","family":"Kiss","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University, Budapest, Hungary"},{"name":"Department of Intensive Therapy, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Zubek","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University, Budapest, Hungary"},{"name":"Department of Intensive Therapy, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilan M\u00e1rk","family":"Karim","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University, Budapest, Hungary"},{"name":"Department of Intensive Therapy, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University, Budapest, Hungary"},{"name":"Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary"},{"name":"Institute for Translational Medicine, University of P\u00e9cs Medical School, P\u00e9cs, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-4058","authenticated-orcid":false,"given":"Zsolt","family":"Moln\u00e1r","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University, Budapest, Hungary"},{"name":"Department of Intensive Therapy, Semmelweis University, Budapest, Hungary"},{"name":"Department of Anaesthesiology and Intensive Therapy, Faculty of Medicine, Poznan University of Medical Sciences, Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2026051307252682000_16.5.e115344.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2717"},{"key":"2026051307252682000_16.5.e115344.2","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-1035-1","article-title":"Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study","volume":"19","author":"Klein Klouwenberg","year":"2015","journal-title":"Crit Care"},{"key":"2026051307252682000_16.5.e115344.3","doi-asserted-by":"crossref","DOI":"10.1186\/cc9961","article-title":"Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units","volume":"15","author":"Montravers","year":"2011","journal-title":"Crit Care"},{"key":"2026051307252682000_16.5.e115344.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med"},{"key":"2026051307252682000_16.5.e115344.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-023-04677-2","article-title":"Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis","volume":"27","author":"Papp","year":"2023","journal-title":"Crit Care"},{"key":"2026051307252682000_16.5.e115344.6","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000005337"},{"key":"2026051307252682000_16.5.e115344.7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31821e8791"},{"key":"2026051307252682000_16.5.e115344.8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318251517a"},{"key":"2026051307252682000_16.5.e115344.9","first-page":"562","article-title":"The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit","volume":"53","author":"Najafi","year":"2015","journal-title":"Acta Med Iran"},{"key":"2026051307252682000_16.5.e115344.10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcrc.2016.04.007","article-title":"Early procalcitonin kinetics and appropriateness of empirical antimicrobial therapy in critically ill patients: A prospective observational study","volume":"34","author":"Tr\u00e1sy","year":"2016","journal-title":"J Crit Care"},{"key":"2026051307252682000_16.5.e115344.11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/BF03018387","article-title":"Procalcitonin levels do not predict mortality following major abdominal surgery","volume":"50","author":"Szakmany","year":"2003","journal-title":"Can J Anaesth"},{"key":"2026051307252682000_16.5.e115344.12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1515\/cclm-2022-1072","article-title":"How to best use procalcitonin to diagnose infections and manage antibiotic treatment","volume":"61","author":"Schuetz","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2026051307252682000_16.5.e115344.13","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/infdis\/jiaa204","article-title":"Neglected Variables in the Interpretation of Serum Procalcitonin Levels in Patients With Septic Shock","volume":"222","author":"Gilbert","year":"2020","journal-title":"J Infect Dis"},{"key":"2026051307252682000_16.5.e115344.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00053-0"},{"key":"2026051307252682000_16.5.e115344.15","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002321"},{"key":"2026051307252682000_16.5.e115344.16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1515\/cclm-2014-1015","article-title":"Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective","volume":"53","author":"Schuetz","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2026051307252682000_16.5.e115344.17","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-9-213","article-title":"Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay","volume":"9","author":"Tsangaris","year":"2009","journal-title":"BMC Infect Dis"},{"key":"2026051307252682000_16.5.e115344.18","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3530752","article-title":"Delta Procalcitonin Is a Better Indicator of Infection Than Absolute Procalcitonin Values in Critically Ill Patients: A Prospective Observational Study","volume":"2016","author":"Tr\u00e1sy","year":"2016","journal-title":"J Immunol Res"},{"key":"2026051307252682000_16.5.e115344.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103384","article-title":"The prevalence and risk of mortality associated with antimicrobial resistance within nosocomial settings-a global systematic review and meta-analysis of over 20,000 patients","volume":"87","author":"George","year":"2025","journal-title":"EClinicalMedicine"},{"key":"2026051307252682000_16.5.e115344.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081660","article-title":"SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials","volume":"389","author":"Hr\u00f3bjartsson","year":"2025","journal-title":"BMJ"},{"key":"2026051307252682000_16.5.e115344.21","unstructured":"REDCap, 2025. Available: https:\/\/project-redcap.org"},{"key":"2026051307252682000_16.5.e115344.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61879-1"},{"key":"2026051307252682000_16.5.e115344.23","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jamainternmed.2016.2514","article-title":"Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial","volume":"176","author":"Bloos","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2026051307252682000_16.5.e115344.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0289"},{"key":"2026051307252682000_16.5.e115344.25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7180\/kmj.24.155","article-title":"Comparative analysis of Access PCT and Elecsys BRAHMS PCT assays for procalcitonin measurements","volume":"39","author":"Choi","year":"2024","journal-title":"KMJ"},{"key":"2026051307252682000_16.5.e115344.26","unstructured":"Harrison PF , Lederberg J , eds. Forum on emerging infections. Antimicrobial resistance: issues and options: workshop report. Washington, DC: National Academies Press, 1998."},{"key":"2026051307252682000_16.5.e115344.27","unstructured":"European Centre for Disease Prevention and Control . Healthcare-associated infections acquired in intensive care units, Available: https:\/\/www.ecdc.europa.eu\/en\/healthcare-associated-infections-acquired-intensive-care-units"},{"key":"2026051307252682000_16.5.e115344.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201703-0621ED"},{"key":"2026051307252682000_16.5.e115344.29","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-021-03813-0","article-title":"Equilibrating SSC guidelines with individualized care","volume":"25","author":"Vincent","year":"2021","journal-title":"Crit Care"},{"key":"2026051307252682000_16.5.e115344.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703058"},{"key":"2026051307252682000_16.5.e115344.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70151-2"},{"key":"2026051307252682000_16.5.e115344.32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa059"},{"key":"2026051307252682000_16.5.e115344.33","doi-asserted-by":"crossref","DOI":"10.1186\/cc13755","article-title":"Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study","volume":"18","author":"Bloos","year":"2014","journal-title":"Crit Care"},{"key":"2026051307252682000_16.5.e115344.34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/14737159.2017.1324299","article-title":"Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis","volume":"17","author":"Schuetz","year":"2017","journal-title":"Expert Rev Mol Diagn"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-115344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:26:10Z","timestamp":1778682370000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-115344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,13]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2025-115344"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-115344","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}